NeuroMetrix Announces Launch of Quell Sport Electrode
NeuroMetrix, Inc. (Nasdaq: NURO) today announced commercial launch of a new Sport Electrode for its innovative Quell®
Wearable Pain Relief Technology™. The new electrode has a special hydrogel designed to better hold up in situations with high
humidity and perspiration. The Sport Electrode absorbs less moisture, but is otherwise comparable to the original Quell Electrode.
It is available at QuellRelief.com.
"We want everyone who is using Quell for chronic pain relief to have the best experience possible," said Frank McGillin,
Senior Vice President and General Manager, Consumer. “While the majority of Quell users will experience optimal performance with
the original electrode, we developed the Sport Electrode in response to consumer feedback indicating the need for another option
for situations with high humidity and perspiration.”
About Quell
Quell is FDA cleared and designed for the millions of people suffering from chronic pain. The advanced wearable technology
delivers 100% drug free relief and is available without a prescription. Quell can be used during the day while active, and at night
while sleeping. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell gives users the option
to start, stop, and adjust therapy discreetly via their smartphone. It also enables advanced sleep tracking that provides feedback
on eight dimensions of sleep including sleep duration, quality, body position, time out of bed, and repetitive leg movements
throughout the night. Quell is available at select healthcare professionals and retailers. To find a Quell retailer near you, visit
the Store Locator at QuellRelief.com.
About NeuroMetrix
NeuroMetrix is an innovative healthcare company that develops wearable medical technology and point-of-care tests that help
patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham,
Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
For more information, please visit www.NeuroMetrix.com.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20160707005311r1&sid=mstr2&distro=nx&lang=en)
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160707005311/en/